• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中度至重度症状性良性前列腺增生(BPH)患者下尿路症状(LUTS)、BPH诊断指标与勃起功能障碍之间的关系。

The relationship between lower urinary tract symptoms (LUTS), diagnostic indicators of benign prostatic hyperplasia (BPH), and erectile dysfunction in patients with moderate to severely symptomatic BPH.

作者信息

Ozayar Asim, Zumrutbas Ali Ersin, Yaman Onder

机构信息

Department of Urology, University of Ankara, School of Medicine, Ibni Sina Hastanesi, Samanpazari, Ankara, 06100, Turkey.

出版信息

Int Urol Nephrol. 2008;40(4):933-9. doi: 10.1007/s11255-008-9386-z. Epub 2008 Apr 24.

DOI:10.1007/s11255-008-9386-z
PMID:18437522
Abstract

PURPOSE

To evaluate the relationship between lower urinary tract symptoms (LUTS), different diagnostic indicators of benign prostatic hyperplasia (BPH), and erectile dysfunction (ED) in a selected group of BPH patients with moderate-or-severe symptoms, for whom either transurethral or open prostatectomy was planned.

MATERIALS AND METHODS

Between 2003 and 2006, 453 patients were included in this study. LUTS and ED were assessed by validated symptom scales. Maximum and average urine flow rates and post-void residual urine volumes (PVRU) of all patients were measured. Additionally, prostate volumes for all patients were detected with transrectal ultrasound (TRUS).

RESULTS

The incidence of LUTS and ED increased significantly with aging (P < 0.001). ED was reported to be 36% in men with moderate LUTS and 94% in men with severe LUTS (P < 0.001). The odds ratio for ED was 28.7 for severe LUTS. When age, IPSS, and IIEF scores were analyzed we observed that the occurrence of LUTS is an age-independent risk factor for the development of ED (P < 0.001). There was a positive correlation between IIEF score, Q (max) (r = 0.441, P < 0.001), and Q (ave) (r = 0.326, P < 0.001), and a negative correlation was found between IIEF score, prostate volume (r = -0.299, P < 0.001), and PVRU (r = -0.486, P < 0.001).

CONCLUSIONS

The presence of LUTS, particularly severe LUTS, is an independent risk factor for ED. It is crucial to assess ED of the patient before BPH surgery, otherwise ED may be regarded as an outcome of the surgery rather than a preoperative, already existing condition.

摘要

目的

在一组计划接受经尿道或开放性前列腺切除术、有中度至重度症状的良性前列腺增生(BPH)患者中,评估下尿路症状(LUTS)、BPH不同诊断指标与勃起功能障碍(ED)之间的关系。

材料与方法

2003年至2006年期间,453例患者纳入本研究。通过经过验证的症状量表评估LUTS和ED。测量所有患者的最大尿流率、平均尿流率和排尿后残余尿量(PVRU)。此外,用经直肠超声(TRUS)检测所有患者的前列腺体积。

结果

LUTS和ED的发生率随年龄增长显著增加(P < 0.001)。据报告,中度LUTS男性的ED发生率为36%,重度LUTS男性为94%(P < 0.001)。重度LUTS的ED比值比为28.7。在分析年龄、国际前列腺症状评分(IPSS)和国际勃起功能指数(IIEF)评分时,我们观察到LUTS的发生是ED发生的一个与年龄无关的危险因素(P < 0.001)。IIEF评分与最大尿流率(Q(max))(r = 0.441,P < 0.001)和平均尿流率(Q(ave))(r = 0.326,P < 0.001)呈正相关,而IIEF评分与前列腺体积(r = -0.299,P < 0.001)和PVRU(r = -0.486,P < 0.001)呈负相关。

结论

LUTS的存在,尤其是重度LUTS,是ED的独立危险因素。在BPH手术前评估患者的ED至关重要,否则ED可能被视为手术结果而非术前已存在的状况。

相似文献

1
The relationship between lower urinary tract symptoms (LUTS), diagnostic indicators of benign prostatic hyperplasia (BPH), and erectile dysfunction in patients with moderate to severely symptomatic BPH.中度至重度症状性良性前列腺增生(BPH)患者下尿路症状(LUTS)、BPH诊断指标与勃起功能障碍之间的关系。
Int Urol Nephrol. 2008;40(4):933-9. doi: 10.1007/s11255-008-9386-z. Epub 2008 Apr 24.
2
The role of BPH, lower urinary tract symptoms, and PSA levels on erectile function of Brazilian men who undergo prostate cancer screening.良性前列腺增生、下尿路症状和前列腺特异性抗原水平对接受前列腺癌筛查的巴西男性勃起功能的作用。
J Sex Med. 2008 Jul;5(7):1702-7. doi: 10.1111/j.1743-6109.2007.00713.x.
3
Association of lower urinary tract symptom/benign prostatic hyperplasia measures with international index of erectile function 5 in middle-aged policemen of Korea and the role of metabolic syndrome and testosterone in their relationship.韩国中年警察的下尿路症状/良性前列腺增生措施与国际勃起功能指数 5 的关系,以及代谢综合征和睾酮在其中的作用。
Urology. 2013 Nov;82(5):1008-12. doi: 10.1016/j.urology.2013.07.003. Epub 2013 Sep 13.
4
Correlation of Subjective Symptoms in Patients with Benign Prostatic Hyperplasia and Erectile Dysfunction.良性前列腺增生症患者主观症状与勃起功能障碍的相关性
Med Arch. 2017 Feb;71(1):32-36. doi: 10.5455/medarh.2017.71.32-36. Epub 2017 Feb 5.
5
Effects of tadalafil on lower urinary tract symptoms secondary to benign prostatic hyperplasia and on erectile dysfunction in sexually active men with both conditions: analyses of pooled data from four randomized, placebo-controlled tadalafil clinical studies.他达拉非对良性前列腺增生继发的下尿路症状及对同时患有这两种病症的性活跃男性勃起功能障碍的影响:来自四项随机、安慰剂对照他达拉非临床研究的汇总数据分析
J Sex Med. 2013 Aug;10(8):2044-52. doi: 10.1111/jsm.12212. Epub 2013 Jun 19.
6
A new experimental rat model of erectile dysfunction and lower urinary tract symptoms associated with benign prostatic hyperplasia: the testosterone-supplemented spontaneously hypertensive rat.一种新型与良性前列腺增生相关的勃起功能障碍和下尿路症状的实验性大鼠模型:补充睾酮的自发性高血压大鼠。
BJU Int. 2012 Nov;110(9):1352-8. doi: 10.1111/j.1464-410X.2012.11085.x. Epub 2012 Mar 27.
7
Efficacy and Safety of a Fixed-Dose Combination Therapy of Tamsulosin and Tadalafil for Patients With Lower Urinary Tract Symptoms and Erectile Dysfunction: Results of a Randomized, Double-Blinded, Active-Controlled Trial.坦索罗辛与他达拉非固定剂量联合治疗下尿路症状和勃起功能障碍患者的疗效与安全性:一项随机、双盲、活性对照试验的结果
J Sex Med. 2017 Aug;14(8):1018-1027. doi: 10.1016/j.jsxm.2017.06.006.
8
[Influences of erectile functions in benign prostatic hyperplasia patients by two micro (thulium) laser resection of prostate-tangerine technique].[两种微(铥)激光前列腺剜除术对良性前列腺增生症患者勃起功能的影响]
Zhonghua Yi Xue Za Zhi. 2011 Aug 30;91(32):2243-6.
9
Tadalafil once daily in the treatment of lower urinary tract symptoms (LUTS) suggestive of benign prostatic hyperplasia (BPH) in men without erectile dysfunction.他达拉非每日一次治疗男性下尿路症状(LUTS)合并良性前列腺增生(BPH)而无勃起功能障碍。
BJU Int. 2013 Nov;112(7):990-7. doi: 10.1111/bju.12251. Epub 2013 Aug 13.
10
Erectile dysfunction and lower urinary tract symptoms associated with benign prostatic hyperplasia (LUTS/BPH) combined responders to tadalafil after 12 weeks of treatment.勃起功能障碍与良性前列腺增生相关的下尿路症状(LUTS/BPH)在接受他达拉非治疗12周后联合有效。
BJU Int. 2016 Jul;118(1):153-60. doi: 10.1111/bju.13406. Epub 2016 Feb 11.

引用本文的文献

1
Benign Prostatic Hyperplasia and Sexual Dysfunction: Review of the Impact of New Medical and Surgical Therapies on Sexual Health.良性前列腺增生与性功能障碍:新型药物及手术治疗对性健康影响的综述
Curr Urol Rep. 2025 Jun 9;26(1):49. doi: 10.1007/s11934-025-01279-z.
2
Erectile dysfunction associated with prostate cancer treatment and therapeutic advances: a narrative review.与前列腺癌治疗相关的勃起功能障碍及治疗进展:一项叙述性综述
Transl Androl Urol. 2024 Nov 30;13(11):2625-2643. doi: 10.21037/tau-24-514. Epub 2024 Nov 28.
3
Lower Urinary Tract Symptoms and Sexual Dysfunction in Male: A Systematic Review and Meta-Analysis.

本文引用的文献

1
Phosphodiesterases (PDEs) and PDE inhibitors for treatment of LUTS.用于治疗下尿路症状的磷酸二酯酶(PDEs)和磷酸二酯酶抑制剂
Neurourol Urodyn. 2007 Oct;26(6 Suppl):928-33. doi: 10.1002/nau.20485.
2
Sildenafil citrate improves erectile function and urinary symptoms in men with erectile dysfunction and lower urinary tract symptoms associated with benign prostatic hyperplasia: a randomized, double-blind trial.枸橼酸西地那非可改善伴有良性前列腺增生相关勃起功能障碍和下尿路症状男性的勃起功能及尿路症状:一项随机双盲试验。
J Urol. 2007 Mar;177(3):1071-7. doi: 10.1016/j.juro.2006.10.055.
3
Combination of alfuzosin and sildenafil is superior to monotherapy in treating lower urinary tract symptoms and erectile dysfunction.
男性下尿路症状与性功能障碍:一项系统评价与荟萃分析
Front Med (Lausanne). 2021 May 28;8:653510. doi: 10.3389/fmed.2021.653510. eCollection 2021.
4
Defining the Efficacy and Safety of Phosphodiesterase Type 5 Inhibitors with Tamsulosin for the Treatment of Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia with or without Erectile Dysfunction: A Network Meta-Analysis.定义磷酸二酯酶 5 抑制剂联合坦索罗辛治疗良性前列腺增生伴或不伴勃起功能障碍下尿路症状的疗效和安全性:网络荟萃分析。
Biomed Res Int. 2020 Mar 26;2020:1419520. doi: 10.1155/2020/1419520. eCollection 2020.
5
Correlation of Subjective Symptoms in Patients with Benign Prostatic Hyperplasia and Erectile Dysfunction.良性前列腺增生症患者主观症状与勃起功能障碍的相关性
Med Arch. 2017 Feb;71(1):32-36. doi: 10.5455/medarh.2017.71.32-36. Epub 2017 Feb 5.
6
The Correlation Between Prostate Volume in Patients with Benign Prostatic Hyperplasia in Relation to Erectile Dysfunction.良性前列腺增生患者前列腺体积与勃起功能障碍的相关性
Med Arch. 2016 Dec;70(6):449-452. doi: 10.5455/medarh.2016.70.449-452.
7
The impact of surgical treatments for lower urinary tract symptoms/benign prostatic hyperplasia on male erectile function: A systematic review and network meta-analysis.下尿路症状/良性前列腺增生手术治疗对男性勃起功能的影响:一项系统评价和网状Meta分析
Medicine (Baltimore). 2016 Jun;95(24):e3862. doi: 10.1097/MD.0000000000003862.
8
Prevalence and risk factors for erectile dysfunction and lower urinary tract symptoms in Russian Federation men: analysis from a national population-based multicenter study.俄罗斯男性勃起功能障碍和下尿路症状的患病率及危险因素:一项基于全国人口的多中心研究分析
Int J Impot Res. 2016 Mar-Apr;28(2):74-9. doi: 10.1038/ijir.2016.8. Epub 2016 Feb 11.
9
Phosphodiesterase type 5 inhibitors for treating erectile dysfunction and lower urinary tract symptoms secondary to benign prostatic hyperplasia: A comprehensive review.用于治疗勃起功能障碍和良性前列腺增生继发下尿路症状的5型磷酸二酯酶抑制剂:一项综述
Arab J Urol. 2015 Sep;13(3):155-61. doi: 10.1016/j.aju.2015.06.004. Epub 2015 Jul 10.
10
Urinary Tract Symptoms (LUTS) Secondary to Benign Prostatic Hyperplasia (BPH) and LUTS/BPH with Erectile Dysfunction in Asian Men: A Systematic Review Focusing on Tadalafil.亚洲男性良性前列腺增生(BPH)继发的下尿路症状(LUTS)以及伴有勃起功能障碍的LUTS/BPH:聚焦他达拉非的系统评价
World J Mens Health. 2013 Dec;31(3):193-207. doi: 10.5534/wjmh.2013.31.3.193. Epub 2013 Dec 24.
阿夫唑嗪与西地那非联合治疗在改善下尿路症状和勃起功能障碍方面优于单一疗法。
Eur Urol. 2007 Jun;51(6):1717-23. doi: 10.1016/j.eururo.2007.01.033. Epub 2007 Jan 16.
4
Assessment of the impact of sildenafil citrate on lower urinary tract symptoms in men with erectile dysfunction.枸橼酸西地那非对勃起功能障碍男性下尿路症状影响的评估。
J Sex Med. 2006 Jul;3(4):662-667. doi: 10.1111/j.1743-6109.2006.00259.x.
5
Association between lower urinary tract symptoms and erectile dysfunction.下尿路症状与勃起功能障碍之间的关联。
Urology. 2004 Oct;64(4):772-6. doi: 10.1016/j.urology.2004.05.025.
6
The link between LUTS and ED: clinical and basic science evidence.下尿路症状与勃起功能障碍之间的联系:临床及基础科学证据。
J Androl. 2004 Jul-Aug;25(4):470-8. doi: 10.1002/j.1939-4640.2004.tb02818.x.
7
Obstructive lower urinary tract symptoms correlate with erectile dysfunction.下尿路梗阻症状与勃起功能障碍相关。
Urology. 2004 Jun;63(6):1148-52. doi: 10.1016/j.urology.2004.01.039.
8
Lower urinary tract symptoms and male sexual dysfunction: the multinational survey of the aging male (MSAM-7).下尿路症状与男性性功能障碍:老年男性多国调查(MSAM-7)
Eur Urol. 2003 Dec;44(6):637-49. doi: 10.1016/j.eururo.2003.08.015.
9
The association between lower urinary tract symptoms and erectile dysfunction in four centres: the UrEpik study.四个中心下尿路症状与勃起功能障碍之间的关联:UrEpik研究
BJU Int. 2003 Nov;92(7):719-25. doi: 10.1046/j.1464-410x.2003.04459.x.
10
Lower urinary tract symptoms and erectile dysfunction: co-morbidity or typical "Aging Male" symptoms? Results of the "Cologne Male Survey".下尿路症状与勃起功能障碍:共病还是典型的“老年男性”症状?“科隆男性调查”结果
Eur Urol. 2003 Nov;44(5):588-94. doi: 10.1016/s0302-2838(03)00358-0.